Please note a change in the briefing date, now: 7th Feb 2024- following the original post of the 15th January.
A briefing on this call will be held on 7th February 2024 at 12 noon, including an overview of the scheme and a Q&A session. For those who cannot attend on the day, the briefing will be recorded and shared on Brightspace. Please contact us to receive the link.
The rest of the timeline remains the same.
Process for selecting applications timeline:
| Date | Action |
| 15th January 2024 | Internal Launch of Call |
| 7th February 2024 | Future Leaders Briefing and Q&A for Fellows and mentors – at the Funding Development Briefing. |
| 29th February 2024 | Call opens |
| 1st March 2024 Noon | EoI deadline |
| 4th March 2024 | Applications sent to reviewers |
| w/c 1st April 2024 | Panel Meeting |
| 8th April 2024 | Notify successful FLF/s |
Please contact Eva Papadopoulou or Kate Percival with any queries on the above.
Funding Development Briefing – Spotlight on…UKRI Future Leader Fellowships
UKRI Future Leader Fellowships Round 7 – Internal Process Launched
Funding Development Briefing 16/11/22 Spotlight on: UKRI Future Leader Fellowships










Reminder: Recharge Your Research Routine Next Week for World Wellbeing Week
Boost Your Research Toolkit: Digital Confidence & AI Literacy Workshop – Friday 26 June 10am-12pm
BU students’ publishing success
BU presentation at the University of Bristol
Art and Design: History, Practice and Theory academics – would you like to get more involved in preparing our next REF submission?
Horizon Europe Cluster 3 (Civil Security for Society) 2026 Calls Now Open
MSCA Doctoral Networks 2026 Call Information Webinar
ESRC Festival of Social Science 2026: Application Deadline Extended to Thursday 25 June 2026
Reminder: Register for the ESRC Festival of Social Science 2026 Information Session
ECR Funding Open Call: Research Culture & Community Grant – Apply now
ERC Advanced Grant 2025 Webinar
Update on UKRO services
European research project exploring use of ‘virtual twins’ to better manage metabolic associated fatty liver disease